Philippine Health Research Registry
Display Options
Results List
Results 1 - 8 of 8 research(es) registered in September 2016

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Completed
Project Description:
The primary end-point of the study is to describe the profile of patients with schizophrenia included in the PHIS-MH during this period, based on the disease onset, duration of untreated psychosis and number of psychotic episodes. Moreover, the study aims to determine the clinical outcomes of the patients included in the PHIS-MH system during this ... [read more]
Project Status:
Ongoing
Project Description:
A Phase III Study of the Effects of Multikine on Cancer of the Oral Cavity Open label, randomized, three group study Duration of administration: 3 weeks Reference therapy: Standard of Care (control); Surgical Excision of tumor and involved lymph nodes followed by radiotherapy +/- concurrent chemotherapy ... [read more]
Project Status:
Ongoing
Project Description:
This clinical study is a Multi-national, Multi-center, Phase III, Randomized, Double blinded, Active controlled, Parallel-group Clinical study.Healthy children aged between 12 months and 12 years old, and whose legal representatives such as parents have given written consent to participate in the study, will be examined for screening at Visit 1. Su... [read more]
[4]
 
Project Status:
Completed
Project Description:
Asian multicentre, double blind, randomised, placebo controlled pilot study, to assess the impact of DYSPORT® intramuscular injections when administered within the first 12 weeks after stroke on the time to spasticity progression in adult subjects with upper limb (UL) spasticity
Project Status:
Ongoing
Project Description:
This is a Phase III, randomized, double-blind, multicenter, single country, non-inferiority study to compare the immunological efficacy and safety of GC3110B with GCFLU Quadrivalent inj. in healthy adults aged between 18 to 60 years. The study will be conducted in Philippines with a total of 4 visits. The study will include Screening, Randomization... [read more]
Project Status:
Completed
Project Description:
This randomized, open-label, multicenter Phase 3 study has been designed to compare the efficacy of Lenvatinib versus Sorafenib as a first-line systemic treatment in subjects with unresectable HCC. Randomization will be used in this study, to increase the likelihood that known and unknown subject attributes (e.g., demographics and baseline characte... [read more]
Project Status:
Ongoing
Project Description:
This is a study of pembrolizumab (MK-3475) in participants with previously systemically treated advanced hepatocellular carcinoma (HCC).The primary objectives of this study are to determine 1) Progression-Free Survival (PFS) and 2) Overall Survival (OS) of pembrolizumab plus best supportive care (BSC) compared with placebo plus BSC. The primary hyp... [read more]
Project Status:
Ongoing
Project Description:
The study is a Phase 1, single-centre, double-blind, placebo-controlled, randomized, ascending multiple-dose study to assess the safety, tolerability, pharmacokinetic and pharmacokinetic profiles of voclosporin. Each treatment group will consist of ten subjects: eight subjects will receive voclosporin and two subjects will receive placebo (8:2 rati... [read more]